TCON Proyeksi bathi mangsa ngarep TRACON

Simbol lan logo merek TRACON Pharmaceuticals Inc. (TCON)

TRACON Pharmaceuticals (TCON) has halted trials and reduced headcount in an effort to monetize its patents. The company previously developed envafolimab antibodies and IT systems for testing. A real-time assessment of future earnings indicates that the parameter equals . Furthermore, success in oncology remains independent of macroeconomics or GDP, as demand for cancer therapy stays stable regardless of market cycles.

TRACON Pharmaceuticals (TCON): Bathi resik sing dikarepake saka 04.07.2022 nganti 17.11.2026

TRACON Pharmaceuticals, Inc - rincian analitis lan metrik utama (TCON)

- rega saham lan konsensus proyeksi valuasi:
Ringkesan analitik perusahaan:TRACON Pharmaceuticals, Inc., TCON
Produk merek TRACON

The selection of defensive assets is based on the stability of expected cash flows. TRACON Pharmaceuticals (TCON) minimizes risks by providing IT infrastructure for third-party oncology research. This metric aggregates analyst expectations for net income, filtering out market noise. By analyzing the consensus earnings forecast for TRACON Pharmaceuticals (TCON), an investor assesses future business efficiency relative to the current price. Overpaying for inflated growth expectations creates the risk of a deep price correction.

Analisis pesaing TRACON Pharmaceuticals

Bathi sing dikarepake Tempus AI|Proyeksi bathi mangsa ngarep Qiagen|Proyeksi bathi mangsa ngarep IONS|Bathi sing dikarepake RGEN (Repligen Corp.)|Avidity - Bathi mangsa ngarep|CRSP (crisprtx.com) - Bathi forward|WGS: Bathi mangsa ngarep|Proyeksi bathi resik Ultragenyx (RARE)|BEAM: Proyeksi bathi mangsa ngarep|Sarepta Therapeutics, Inc. (SRPT) - Proyeksi bathi mangsa ngarep|TWST (twistbioscience.com) - Proyeksi bathi mangsa ngarep|10x Genomics, Inc. (TXG) - Prakiraan bathi perusahaan|Bathi mangsa ngarep NTLA (Intellia Therapeutics, Inc.)|STOK - Bathi resik sing dikarepake|Bathi sing dikarepake biolifesolutions.com BLFS|Prakiraan bathi perusahaan Wave Life Sciences Corp (WVE)|MAZE - Bathi sing dikarepake|Penghasilan resik sing dikarepake SION (Sionna Therapeutics Inc)|PRME: Proyeksi bathi mangsa ngarep|Taysha - Penghasilan resik sing dikarepake|Bathi sing dikarepake uniQure NV|Prakiraan bathi resik MGTX (MeiraGTx PLC)|Bathi mangsa ngarep RGNX (regenxbio.com)|Solid Biosciences Inc. - Prakiraan bathi resik|Bathi sing dikarepake Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Bathi resik sing dikarepake|BNTC - Bathi sing dikarepake|Design Pharma - Bathi resik mangsa ngarep|RCKT (Rocket Pharmaceuticals Inc) - Bathi mangsa ngarep|4D Molecular Therapeutics (FDMT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Lexeo Therapeutics, Inc.|Bathi resik sing dikarepake Korro Bio, Inc. KRRO|Proyeksi bathi mangsa ngarep EDIT|Prakiraan bathi perusahaan Silence Therapeutics Corp|Bathi sing dikarepake proqr.com PRQR|CDXS - Bathi mangsa ngarep|SGMO - Bathi sing dikarepake|Proyeksi bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik DTIL|GBIO (Generation Bio) - Proyeksi bathi mangsa ngarep|Prakiraan bathi resik BOLD (boundlessbio.com)|Bathi mangsa ngarep XCUR (exicuretx.com)|Celsion Corporation - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep PHIO (phiopharma.com)|Proyeksi bathi mangsa ngarep Mustang Bio, Inc. MBIO|RNAZ: Bathi mangsa ngarep|BNGO (Bionano Genomics) - Prakiraan bathi resik|APDN: Proyeksi bathi mangsa ngarep|bluebird bio (BLUE) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake ImmunoPrecise Antibodies Ltd.|Bathi resik sing dikarepake Omega OMGA|Proyeksi bathi mangsa ngarep OMIC|RGLS - Bathi resik sing dikarepake|Syros Pharmaceuticals, Inc - Bathi mangsa ngarep|Prakiraan bathi perusahaan Codex DNA (TBIO)|Unity Bio - Proyeksi bathi mangsa ngarep